Literature DB >> 35948559

Faecal incontinence in adults.

Adil E Bharucha1, Charles H Knowles2, Isabelle Mack3, Allison Malcolm4, Nicholas Oblizajek5, Satish Rao6, S Mark Scott2, Andrea Shin7, Paul Enck8.   

Abstract

Faecal incontinence, which is defined by the unintentional loss of solid or liquid stool, has a worldwide prevalence of ≤7% in community-dwelling adults and can markedly impair quality of life. Nonetheless, many patients might not volunteer the symptom owing to embarrassment. Bowel disturbances, particularly diarrhoea, anal sphincter trauma (obstetrical injury or previous surgery), rectal urgency and burden of chronic illness are the main risk factors for faecal incontinence; others include neurological disorders, inflammatory bowel disease and pelvic floor anatomical disturbances. Faecal incontinence is classified by its type (urge, passive or combined), aetiology (anorectal disturbance, bowel symptoms or both) and severity, which is derived from the frequency, volume, consistency and nature (urge or passive) of stool leakage. Guided by the clinical features, diagnostic tests and therapies are implemented stepwise. When simple measures (for example, bowel modifiers such as fibre supplements, laxatives and anti-diarrhoeal agents) fail, anorectal manometry and other tests (endoanal imaging, defecography, rectal compliance and sensation, and anal neurophysiological tests) are performed as necessary. Non-surgical options (diet and lifestyle modification, behavioural measures, including biofeedback therapy, pharmacotherapy for constipation or diarrhoea, and anal or vaginal barrier devices) are often effective, especially in patients with mild faecal incontinence. Thereafter, perianal bulking agents, sacral neuromodulation and other surgeries may be considered when necessary.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35948559     DOI: 10.1038/s41572-022-00381-7

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   65.038


  279 in total

Review 1.  Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders.

Authors:  Adil E Bharucha; Satish S C Rao; Andrea S Shin
Journal:  Clin Gastroenterol Hepatol       Date:  2017-08-22       Impact factor: 11.382

2.  Treatment of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases workshop.

Authors:  William E Whitehead; Satish S C Rao; Ann Lowry; Deborah Nagle; Madhulika Varma; Khalil N Bitar; Adil E Bharucha; Frank A Hamilton
Journal:  Am J Gastroenterol       Date:  2014-10-21       Impact factor: 10.864

3.  Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop.

Authors:  Adil E Bharucha; Gena Dunivan; Patricia S Goode; Emily S Lukacz; Alayne D Markland; Catherine A Matthews; Louise Mott; Rebecca G Rogers; Alan R Zinsmeister; William E Whitehead; Satish S C Rao; Frank A Hamilton
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

4.  ACG Clinical Guidelines: Management of Benign Anorectal Disorders.

Authors:  Arnold Wald; Adil E Bharucha; Berkeley Limketkai; Allison Malcolm; Jose M Remes-Troche; William E Whitehead; Massarat Zutshi
Journal:  Am J Gastroenterol       Date:  2021-10-01       Impact factor: 10.864

5.  Randomized controlled trial of biofeedback for fecal incontinence.

Authors:  Christine Norton; Sonya Chelvanayagam; Jenifer Wilson-Barnett; Sally Redfern; Michael A Kamm
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

6.  Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence.

Authors:  A E Bharucha; J G Fletcher; C M Harper; D Hough; J R Daube; C Stevens; B Seide; S J Riederer; A R Zinsmeister
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

7.  Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence.

Authors:  Steve Heymen; Yolanda Scarlett; Kenneth Jones; Yehuda Ringel; Douglas Drossman; William E Whitehead
Journal:  Dis Colon Rectum       Date:  2009-10       Impact factor: 4.585

Review 8.  The perspective of the patient.

Authors:  Nancy J Norton
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

Review 9.  Fecal Incontinence: Community Prevalence and Associated Factors--A Systematic Review.

Authors:  Kheng-Seong Ng; Yogeesan Sivakumaran; Natasha Nassar; Marc A Gladman
Journal:  Dis Colon Rectum       Date:  2015-12       Impact factor: 4.585

10.  Comparative effectiveness of biofeedback and injectable bulking agents for treatment of fecal incontinence: Design and methods.

Authors:  Adil E Bharucha; Marie G Gantz; Satish S Rao; Ann C Lowry; Heidi Chua; Tennekoon Karunaratne; Jennifer Wu; Frank A Hamilton; William E Whitehead
Journal:  Contemp Clin Trials       Date:  2021-06-15       Impact factor: 2.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.